IHS Chemical Week

World News and Views :: Top of the News

DSM to Acquire Kensey Nash for $360 Million to Strengthen Biomedical Business

3:14 AM MDT | May 3, 2012 | Deepti Ramesh

DSM says it will acquire Kensey Nash (Exton, PA), a technology-driven biomedical company, for about $360 million. DSM has entered into a definitive agreement with Kensey Nash, under which DSM would acquire all the outstanding shares of common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.5/share in cash for a total enterprise value of about $360 million. The transaction has been approved by DSM’s supervisory board and by Kensey Nash’s board of directors. The agreed price represents a premium...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa